NCT07327736

Brief Summary

This study is a prospective, randomized, controlled study, which intends to enroll patients with suspected early-stage NSCLC (non-small cell lung cancer) with a diameter of ≤ 3 cm as research subjects. The study is conducted in accordance with the Declaration of Helsinki. It has been approved by the Ethics Committee of the Second Affiliated Hospital of Air Force Medical University, and patients or their family members have signed the informed consent form. Patients undergoing VATS (video-assisted thoracic surgery) are enrolled in the Department of Thoracic Surgery of the Second Affiliated Hospital of Air Force Medical University. The patients are randomly divided into two groups: the NIVATS (non-intubated video-assisted thoracic surgery) group and the OLV (one-lung ventilation) group. By observing various perioperative indicators of the patients, the short-term efficacy of the two techniques in patients with early-stage NSCLC is compared, so as to evaluate the safety and effectiveness of the NIVATS surgical treatment method.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
410

participants targeted

Target at P75+ for not_applicable

Timeline
82mo left

Started Mar 2026

Longer than P75 for not_applicable

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress1%
Mar 2026Dec 2032

First Submitted

Initial submission to the registry

December 11, 2025

Completed
28 days until next milestone

First Posted

Study publicly available on registry

January 8, 2026

Completed
2 months until next milestone

Study Start

First participant enrolled

March 15, 2026

Completed
2.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 30, 2028

Expected
4.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2032

Last Updated

March 12, 2026

Status Verified

March 1, 2026

Enrollment Period

2.3 years

First QC Date

December 11, 2025

Last Update Submit

March 10, 2026

Conditions

Outcome Measures

Primary Outcomes (2)

  • Average postoperative hospital stay

    up to 3 months

  • Intraoperative opioid consumption

    1 day

Secondary Outcomes (10)

  • Lung collapse score

    1 day

  • Intraoperative blood gas analysis (Q1h)

    1 day

  • Conversion to intubation rate

    1 day

  • Postoperative awakening time

    1 day

  • Time to first ambulation after surgery

    up to 3 months

  • +5 more secondary outcomes

Other Outcomes (4)

  • The impact of nursing education on discharge time and time to first ambulation after surgery

    up to 3 months

  • Comparison of the effects of thoracic paravertebral nerve block and intrathoracic intercostal nerve block

    up to 3 months

  • 1-, 3-, and 5-year disease-free survival (DFS)

    up to 5 years

  • +1 more other outcomes

Study Arms (2)

group A

EXPERIMENTAL

Non-intubated video-assisted thoracic surgery with spontaneous breathing (NIVATS)

Procedure: Non-intubated video-assisted thoracic surgery with spontaneous breathing (NIVATS)

group B

PLACEBO COMPARATOR

Tracheal Intubation with One-Lung Ventilation Group (OLV)

Procedure: Non-intubated video-assisted thoracic surgery with spontaneous breathing (NIVATS)

Interventions

NIVATS is a special method developed in the past two decades. It means that patients do not undergo tracheal intubation under general anesthesia during the entire surgical process, retaining their spontaneous breathing, but supraglottic airway devices (such as laryngeal masks, high-flow nasal catheters, mask ventilation) can be used to support their breathing. The purpose of this technology is to minimize the impact of general anesthesia, tracheal intubation, mechanical ventilation, etc. on patients.

group Agroup B

Eligibility Criteria

AgeUp to 75 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≤ 75 years;
  • Gender is not limited;
  • Patients with suspected T1 stage non-small cell lung cancer (NSCLC) in preoperative clinical staging, with thin-slice CT showing that the maximum tumor diameter is ≤ 3.0 cm, single or multiple nodules, and the nodules requiring surgical resection are located in the same ipsilateral lung lobe, with the number of nodules resected simultaneously ≤ 3;
  • American Society of Anesthesiologists (ASA) classification ≤ Grade III (preferably Grade I - II is recommended);
  • Eastern Cooperative Oncology Group (ECOG) performance status 0 - 1;
  • Body Mass Index (BMI) \< 25 kg·m-²;
  • Normal cardiopulmonary function: predicted forced expiratory volume in the first second (FEV1%) \> 50%, resting blood gas analysis showing arterial oxygen partial pressure (PaO2) ≥ 75 mmHg, arterial carbon dioxide partial pressure (PaCO2) \< 45 mmHg; ejection fraction (EF) \> 50%, 6-minute walk distance (6MWD) ≥ 350 m;
  • No severe upper airway lesions, Mallampati classification I - II;
  • No contraindications related to paravertebral nerve block and intercostal nerve block;
  • Estimated surgical time ≤ 150 minutes;
  • Patients have no history of clinically significant cardiac or neurological problems.

You may not qualify if:

  • A history of ipsilateral lung surgery;
  • Interstitial pneumonia, pulmonary fibrosis, severe emphysema, severe chronic obstructive pulmonary disease, acute phase of pulmonary infection, or uncontrolled asthma;
  • Sleep apnea syndrome with anticipated airway difficulty or difficulty in airway management;
  • Preoperative complications including coagulation dysfunction, hypoxemia, hypercapnia, or hepatic/renal insufficiency;
  • Alteration of anesthesia or surgical plan;
  • Persistent cough or increased risk of high airway secretion reflux;
  • Mental disorders, inability to communicate, or refusal to sign the informed consent form;
  • Participation in other clinical trials within 1 month before this trial;
  • Those who are deemed unfit to participate in this trial by the researchers.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (8)

  • Pompeo E, Mineo D, Rogliani P, Sabato AF, Mineo TC. Feasibility and results of awake thoracoscopic resection of solitary pulmonary nodules. Ann Thorac Surg. 2004 Nov;78(5):1761-8. doi: 10.1016/j.athoracsur.2004.05.083.

    PMID: 15511470BACKGROUND
  • Pompeo E. State of the art and perspectives in non-intubated thoracic surgery. Ann Transl Med. 2014 Nov;2(11):106. doi: 10.3978/j.issn.2305-5839.2014.10.01.

    PMID: 25489580BACKGROUND
  • Chiang XH, Lin MW. Converting to Intubation During Non-intubated Thoracic Surgery: Incidence, Indication, Technique, and Prevention. Front Surg. 2021 Oct 26;8:769850. doi: 10.3389/fsurg.2021.769850. eCollection 2021.

    PMID: 34765639BACKGROUND
  • Lohser J, Slinger P. Lung Injury After One-Lung Ventilation: A Review of the Pathophysiologic Mechanisms Affecting the Ventilated and the Collapsed Lung. Anesth Analg. 2015 Aug;121(2):302-18. doi: 10.1213/ANE.0000000000000808.

    PMID: 26197368BACKGROUND
  • Hung WT, Hung MH, Wang ML, Cheng YJ, Hsu HH, Chen JS. Nonintubated Thoracoscopic Surgery for Lung Tumor: Seven Years' Experience With 1,025 Patients. Ann Thorac Surg. 2019 Jun;107(6):1607-1612. doi: 10.1016/j.athoracsur.2019.01.013. Epub 2019 Feb 11.

    PMID: 30763562BACKGROUND
  • Gelzinis TA, Sullivan EA. Non-Intubated General Anesthesia for Video-Assisted Thoracoscopic Surgery. J Cardiothorac Vasc Anesth. 2017 Apr;31(2):407-408. doi: 10.1053/j.jvca.2016.12.027. Epub 2016 Dec 23. No abstract available.

    PMID: 28320572BACKGROUND
  • Janik M, Juhos P, Lucenic M, Tarabova K. Non-intubated Thoracoscopic Surgery-Pros and Cons. Front Surg. 2021 Dec 6;8:801718. doi: 10.3389/fsurg.2021.801718. eCollection 2021.

    PMID: 34938770BACKGROUND
  • Liu J, Cui F, He J. Non-intubated video-assisted thoracoscopic surgery anatomical resections: a new perspective for treatment of lung cancer. Ann Transl Med. 2015 May;3(8):102. doi: 10.3978/j.issn.2305-5839.2015.04.18.

    PMID: 26046043BACKGROUND

MeSH Terms

Conditions

Carcinoma, Non-Small-Cell Lung

Condition Hierarchy (Ancestors)

Carcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsNeoplasms by SiteNeoplasmsLung DiseasesRespiratory Tract Diseases

Central Study Contacts

Xiaolong Yan, Doctor of Medicine (M.D.)

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 11, 2025

First Posted

January 8, 2026

Study Start

March 15, 2026

Primary Completion (Estimated)

June 30, 2028

Study Completion (Estimated)

December 31, 2032

Last Updated

March 12, 2026

Record last verified: 2026-03

Data Sharing

IPD Sharing
Will not share